This pathway is likely responsible for low-grade inflammation exhibited in T2D (4), which is characterized by increased secretion of pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-α) and interleukin (IL) 6, and acute phase proteins such as C-reactive protein (CRP) levels into systemic circulation (2). The gene discussed is CRP; the disease is type 2 diabetes mellitus.